The 14 analysts offering 12-month price forecasts for BioNTech SE have a median target of 289.12, with a high estimate of 397.51 and a low estimate of 168.46. The median estimate represents a +87.05% increase from the last price of 154.57.
The current consensus among 16 polled investment analysts is to Hold stock in BioNTech SE. This rating has held steady since January, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $7.44
Reporting Date Mar 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.